All case studies
- Diagnostics
Identifying 39 pharma partnership opportunities to shape a world-leading diagnostics company’s 5-year assay pipeline
What we did:
Our diagnostics client’s objective was to be more proactive to identify partnership opportunities with pharma companies who would benefit from new SDx and CDx assays.
We identified opportunities through review of trial registries/ results, protocols, conference presentations, and peer-reviewed literature.
Impact:
Identified 39 opportunities across 19 distinct biomarkers.
Opportunities mapped to 26 pharma assets from seven large pharma companies.
Informed the client's IVD assay pipeline for the next 5 years.